Patents Assigned to University of Queensland
  • Patent number: 10575751
    Abstract: An apparatus is provided for detecting Macro Sleep Architecture states of a subject such as WAKE, NREM and REM sleep from a subject's EEG. The apparatus includes an EEG digital signal assembly of modules arranged to convert analogue EEG signals into digital EEG signals. A bispectrum assembly is responsive to the EEG digital signal assembly and converts the digital EEG signals into signals representing corresponding bispectrum values. A bispectrum time series assembly, in electrical communication with an output side of the bispectrum assembly, generates at least one bispectrum time series for a predetermined frequency. A macro-sleep architecture (MSA) assembly is responsive to the bispectrum time series assembly and is arranged to produce classification signals indicating classification of segments of the EEG signals into macro-sleep states of the subject.
    Type: Grant
    Filed: November 27, 2009
    Date of Patent: March 3, 2020
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Udantha Abeyratne, Vinayak Swarnkar
  • Patent number: 10538487
    Abstract: The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: January 21, 2020
    Assignees: THE UNIVERSITY OF QUEENSLAND, THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
    Inventors: Luke O'Neill, Rebecca Coll, Matthew Cooper, Avril Robertson, Kate Schroder
  • Patent number: 10509172
    Abstract: A tunable optical device comprising an optical ring cavity and one or more pairs of electrodes for capacitive actuation of the optical tuning. Applying a potential difference to the electrodes applies a capacitive force to the optical ring cavity which changes the optical resonance frequency. The device can be used as a binary optical switch.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: December 17, 2019
    Assignee: The University of Queensland
    Inventors: Warwick Bowen, Christopher Baker
  • Patent number: 10494453
    Abstract: Conjugate compounds of hyaluronic acid bonded to pentosan polysulfate, or salts or derivatives thereof, are shown to induce chondrogenic differentiation of a population of mesenchymal stem cells as observed by, amongst other indications, increased glycosaminogSycan (GAG) production.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: December 3, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Justin Cooper-White, Peter Ghosh
  • Publication number: 20190359564
    Abstract: The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Applicants: THE UNIVERSITY OF QUEENSLAND, THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOL
    Inventors: Luke O'NEILL, Rebecca COLL, Matthew COOPER, Avril ROBERTSON, Kate SCHRODER
  • Patent number: 10485847
    Abstract: The invention relates to disulfide-rich peptides derived from spider venom and their use, particularly as neuroprotective agents. The invention also relates to nucleic acid molecules encoding the peptides as well as constructs and host cells comprising those nucleic acid molecules.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: November 26, 2019
    Assignees: THE UNIVERSITY OF QUEENSLAND, MONASH UNIVERSITY
    Inventors: Glenn Frederick King, Lachlan Douglas Rash, Irene Chassagnon, Sandy Steffany Pineda Gonzalez, Robert Edward Widdop, Claudia Ann Ireland
  • Patent number: 10465236
    Abstract: A method and kit for detecting a target nucleic acid is provided wherein combining an amplified nucleic acid with a particle such as a paramagnetic bead form a flocculated complex which can be detected by visual inspection. The volume of nucleic acid sample that can be detected is as low as a few microlitres. The method can be applied to in-the-field or point-of-care diagnosis for a rapid determination of the presence or absence of the target nucleic acid. The methylation status of a target nucleic acid can also be determined. The method and lit may have general applicability to detecting diseases in plants and animals, environmental testing and testing for contamination of foods and other edible products.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: November 5, 2019
    Assignee: University of Queensland
    Inventors: Matt Trau, Eugene Wee, Jose Ramon Botella
  • Patent number: 10442841
    Abstract: An isolated protein that is highly abundant in the seed of wheat varieties with desirable breadmaking qualities is provided. Associated promoters and promoter active fragments are also provided. Further provided are plants or plant parts with improved or enhanced breadmaking properties, and methods of producing such plants, wherein the abundance of the isolated protein is increased or enhanced. Such plants and/or plant parts may be used in the production of plant products, for example bread and read products.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: October 15, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventor: Robert Henry
  • Patent number: 10405539
    Abstract: In one aspect, the present invention relates to a composition for delivery of double stranded RNA to an insect having a basic pH within its alimentary canal, wherein the composition comprises double stranded RNA adsorbed onto a clay complex, and wherein the clay complex is configured to release the double stranded RNA at the basic pH. Other aspects of the invention relate to preparations including the composition of the invention, methods of delivering double stranded RNA to an insect and methods of protecting a crop against an insect.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: September 10, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Neena Mitter, Zhi Ping Xu
  • Publication number: 20190264209
    Abstract: The present invention discloses small plant virus RNA molecules involved in modulating a plant defence response, particularly non-translated, plant viral microRNA molecules. The present invention also provides methods of their production and uses of these microRNA molecules for reducing a susceptibility of a plant to a pathogen.
    Type: Application
    Filed: December 27, 2018
    Publication date: August 29, 2019
    Applicant: The University of Queensland
    Inventors: Peer Schenk, Shazia Iram
  • Patent number: 10351634
    Abstract: An inclusion complex of an amorphous ?-cyclodextrin, or derivative thereof, with encapsulated ethylene is provided by exposure of the dry solid amorphous ?-cyclodextrin to ethylene gas under pressure. The inclusion complex will have applications in a number of fields including fruit ripening.
    Type: Grant
    Filed: October 10, 2013
    Date of Patent: July 16, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Bhesh Bhandari, Binh Thanh Ho
  • Patent number: 10280197
    Abstract: A method of selectively modulating the activity of C5a receptor 2 (C5aR2). The method includes exposing the receptor to a compound that selectively modulates C5aR2 compared to C5a receptor 1 (C5aR1). In some cases, the compound is peptide P32 or P59. Methods of recruiting ?-arrestin 2 in a cell, modulating C5a-induced ERK1/2 activation in a macrophage, selectively inhibiting the release of IL-6 from a macrophage, are also provided.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: May 7, 2019
    Assignees: The Regents of the University of California, The Texas A & M University System, The University of Queensland, The University of Sheffield
    Inventors: Dimitrios Monikis, Christodoulos Floudas, Trent Woodruff, Matthew A. Cooper, Daniel E. Croker, Peter N. Monk
  • Patent number: 10253107
    Abstract: The present invention relates to the use of endocytosis inhibitors, including clathrin-dependent endocytosis inhibitors such as inhibitors of dynamin and antibodies, for enhancing the immune response to cancer, and thereby treating cancers including cancer associated receptor positive cancers.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: April 9, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Fiona Simpson, Nicholas Andrew Saunders
  • Patent number: 10252910
    Abstract: An autothermal reforming catalytic structure for generating hydrogen gas from liquid hydrocarbons, steam and an oxygen source. The autothermal reforming catalytic structure includes a support structure and nanosized mixed metal oxide particles dispersed homogenously throughout the support structure.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: April 9, 2019
    Assignees: Saudi Arabian Oil Company, The University of Queensland
    Inventors: Jorge N. Beltramini, Moses O. Adebajo, Joao Carlos Diniz Da Costa, Gao Qing Lu, Thang V. Pham, Sai P. Katikaneni
  • Patent number: 10252911
    Abstract: An autothermal reforming catalytic structure for generating hydrogen gas from liquid hydrocarbons, steam and an oxygen source. The autothermal reforming catalytic structure includes a support structure and nanosized mixed metal oxide particles dispersed homogenously throughout the support structure.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: April 9, 2019
    Assignees: Saudi Arabian Oil Company, The University of Queensland
    Inventors: Jorge N. Beltramini, Moses O. Adebajo, Joao Carlos Diniz Da Costa, Gao Qing Lu, Thang V. Pham, Sai P. Katikaneni
  • Patent number: 10245262
    Abstract: The present invention provides ligands which bind to MR1, some of which induce MR1 to bind to MAIT cells thereby activating or inhibiting MAIT cell activation.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: April 2, 2019
    Assignees: The University of Queensland, Monash University, The University of Melbourne
    Inventors: Alexandra Jane Corbett, James McCluskey, Lars Kjer-Nielsen, Zhenjun Chen, Jamie Rossjohn, Onisha Patel, Richard William Birkinshaw, Sidonia Barbara Guiomar Eckle, David Paul Fairlie, Ligong Liu, Jeffrey Yam Wing Mak
  • Patent number: 10180397
    Abstract: A THz quantum cascade laser is used to investigate a target by directing a first beam of laser radiation from the laser at the target to thereby produce a second beam of laser radiation by interaction of the first beam with the target. Self-mixing of the first and second beams occurs within the laser and causes variations in a signal such as the operating voltage of the laser. An operating parameter of the laser that affects the interaction of the first beam with, the target is varied. The operating voltage is monitored and processed to determine phase and amplitude changes associated with material properties of the target. Consequently in one embodiment the invention provides for processing the variations in the signal to produce various images of the target.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: January 15, 2019
    Assignees: The University of Queensland, University of Leeds
    Inventors: Aleksandar D. Rakic, Paul Dean, Alexander Giles Davies, Dragan Indjin, Edmund Harold Linfield, Stephen James Wilson, Thomas Taimre, Karl Bertling, Yah Leng Lim
  • Patent number: 10167203
    Abstract: A method for preparing a suspension of LDH particles comprising the steps of: preparing LDH precipitates by coprecipitation to form a mixture of LDH precipitates and solution; separating the LDH precipitates from the solution; washing the LDH precipitates to remove residual ions; mixing the LDH precipitates with water; and subjecting the mixture of LDH particles and water to a hydrothermal treatment step by heating to a temperature of from greater than 80° C. to 150° C. for a period of about 1 hour to about 144 hours to form a well dispersed suspension of LDH particles in water, wherein said LDH particles in suspension comprise platelets having a maximum particle dimension of up to 400 nm.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: January 1, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Gaoqing Lu, Zhiping Xu
  • Patent number: 10156546
    Abstract: A device for the detection of target entities, the device including: a fluidic channel to conduct a liquid sample containing at least one type of target entity to be detected; and mutually spaced electrodes disposed along the fluidic channel; wherein the mutually spaced electrodes are functionalized to selectively bond to the at least one type of target entity and are configured to electro-hydrodynamically pump the liquid sample along the fluidic channel on application of a signal to the electrodes, such that selectivity of attachment of the at least one type of target entity to the electrodes is determined by at least one parameter of the signal.
    Type: Grant
    Filed: February 19, 2014
    Date of Patent: December 18, 2018
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Matt Trau, Muhammad Johirul Alam Shiddiky, Sakandar Rauf, Ramanathan Pudhukode Vaidyanathan
  • Patent number: 10149864
    Abstract: Disclosed are methods for isolating endothelial progenitor cells (EPC). More particularly, the present invention discloses methods for isolating endothelial progenitor cells that exhibit self-renewal and differentiation capacity. The isolated cellular population of the present invention is useful in a wide range of clinical and research setting including inter alia, the in vitro or in vivo generation of endothelial cells and the therapeutic or prophylactic treatment of a range of conditions via the administration of these cells. Also facilitated is the isolation of endothelial progenitor cells for research purposes such as in vitro based screening systems for testing the therapeutic impact and/or toxicity of potential treatment or culture regimes to which these cells may be exposed to. The present invention also discloses methods for isolating mesenchymal stem cells, in particular mesenchymal stem cells of fetal and/or maternal origin.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: December 11, 2018
    Assignee: The University of Queensland
    Inventors: Jatin Patel, Paul Kiarash Khosrotehrani, Nicholas Maxwell Fisk